Outcomes4Me Secures $21M in Funding Learn more >>

Learn | Resources to take control of your cancer

Explore articles on personalized treatment options, clinical trials,
and symptom management to empower every step of your journey.

Every year, the American Society of Clinical Oncology (ASCO) Annual Meeting gathers oncologists from around...
Breast imaging is a complex topic that can be difficult to navigate. We had the...
Safety outcomes with first-line treatment of Enhertu (fam-trastuzumab deruxtecan-nxki; T-DXd) plus Perjeta (pertuzumab) is comparable...
Understanding HER2 as a tumor-agnostic biomarker in cancer care and what it means for treatmentIn...
8 health insurance benefits to ask for after breast cancerA breast cancer diagnosis doesn’t just...
CDK 4/6 inhibitor side effects, treatment length, and moreDr. Pooja Advani is a breast oncologist...
Neither Outcomes4Me nor any participants in or contributors to any webinar, article or content endorses...
Enhertu (fam-trastuzumab deruxtecan-nxki or T-DXd) has shown promising results in slowing down or stopping the...
The American Society of Clinical Oncology (ASCO) Annual Meeting, held in Chicago from May 30...
A recent study is aiming to understand and classify the HER2 protein levels in breast...
One of the most important first steps after receiving a breast cancer diagnosis is understanding...
Every year, the American Society of Clinical Oncology (ASCO) hosts a meeting in Chicago to...
Held in Chicago, the American Society of Clinical Oncology (ASCO) Annual Meeting brings together professionals...
Each year, the American Society of Clinical Oncology (ASCO) hosts its Annual Meeting in Chicago....
What is the gut and tumor microbiome and why does it matter in cancer?Your body...